 Tyler Buckner
Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hemophilia A | 30 | 2024 | 115 | 9.410 |
Why?
| | Hemophilia B | 11 | 2024 | 48 | 3.730 |
Why?
| | Quality of Life | 17 | 2024 | 2704 | 1.920 |
Why?
| | Antibodies, Bispecific | 3 | 2024 | 49 | 1.720 |
Why?
| | Pain | 7 | 2024 | 789 | 1.700 |
Why?
| | Hemarthrosis | 3 | 2023 | 20 | 1.220 |
Why?
| | Anxiety | 7 | 2024 | 966 | 0.910 |
Why?
| | Depression | 7 | 2024 | 1307 | 0.880 |
Why?
| | Pain Management | 3 | 2022 | 327 | 0.870 |
Why?
| | Factor VIII | 6 | 2023 | 87 | 0.870 |
Why?
| | Venous Thromboembolism | 3 | 2024 | 284 | 0.840 |
Why?
| | Patient Reported Outcome Measures | 9 | 2024 | 373 | 0.830 |
Why?
| | Venous Thrombosis | 3 | 2016 | 176 | 0.820 |
Why?
| | Arthroplasty, Replacement, Hip | 2 | 2022 | 137 | 0.770 |
Why?
| | Antibodies, Monoclonal, Humanized | 2 | 2024 | 759 | 0.760 |
Why?
| | Antifibrinolytic Agents | 1 | 2022 | 47 | 0.730 |
Why?
| | Hemorrhage | 6 | 2023 | 678 | 0.710 |
Why?
| | Physical Therapists | 1 | 2022 | 61 | 0.710 |
Why?
| | Surveys and Questionnaires | 14 | 2024 | 5406 | 0.640 |
Why?
| | Pain Measurement | 2 | 2018 | 506 | 0.610 |
Why?
| | Antibodies | 2 | 2015 | 398 | 0.500 |
Why?
| | Factor V Deficiency | 1 | 2014 | 1 | 0.470 |
Why?
| | Adult | 26 | 2024 | 35577 | 0.470 |
Why?
| | Hydroxyurea | 1 | 2014 | 34 | 0.460 |
Why?
| | Postoperative Hemorrhage | 3 | 2022 | 87 | 0.460 |
Why?
| | Anticoagulants | 3 | 2024 | 637 | 0.450 |
Why?
| | United States | 12 | 2023 | 13903 | 0.450 |
Why?
| | Caregivers | 2 | 2018 | 815 | 0.450 |
Why?
| | Opioid-Related Disorders | 1 | 2022 | 484 | 0.450 |
Why?
| | Humans | 45 | 2024 | 129652 | 0.440 |
Why?
| | Severity of Illness Index | 4 | 2024 | 2742 | 0.440 |
Why?
| | Maxillary Sinus | 1 | 2012 | 11 | 0.410 |
Why?
| | Symptom Assessment | 1 | 2014 | 125 | 0.410 |
Why?
| | Disability Evaluation | 1 | 2014 | 284 | 0.390 |
Why?
| | Thrombophlebitis | 1 | 2012 | 10 | 0.390 |
Why?
| | Young Adult | 13 | 2024 | 12427 | 0.380 |
Why?
| | Patient Education as Topic | 1 | 2017 | 743 | 0.380 |
Why?
| | Pulmonary Embolism | 2 | 2012 | 211 | 0.370 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 2012 | 112 | 0.360 |
Why?
| | Warfarin | 1 | 2012 | 147 | 0.360 |
Why?
| | Anemia, Sickle Cell | 1 | 2014 | 254 | 0.360 |
Why?
| | Male | 25 | 2024 | 63682 | 0.350 |
Why?
| | Survivors | 1 | 2014 | 464 | 0.340 |
Why?
| | Delivery of Health Care | 1 | 2017 | 894 | 0.330 |
Why?
| | Middle Aged | 16 | 2024 | 31155 | 0.320 |
Why?
| | Postoperative Complications | 2 | 2022 | 2483 | 0.310 |
Why?
| | Lung Diseases | 1 | 2014 | 742 | 0.290 |
Why?
| | Joint Diseases | 2 | 2018 | 56 | 0.280 |
Why?
| | Adolescent | 10 | 2024 | 20394 | 0.280 |
Why?
| | Genetic Therapy | 3 | 2024 | 292 | 0.280 |
Why?
| | Autopsy | 1 | 2006 | 94 | 0.260 |
Why?
| | Cross-Sectional Studies | 8 | 2024 | 5066 | 0.260 |
Why?
| | Population Surveillance | 2 | 2020 | 439 | 0.260 |
Why?
| | Aged | 8 | 2024 | 22104 | 0.240 |
Why?
| | Neoplasms | 2 | 2024 | 2470 | 0.240 |
Why?
| | Cause of Death | 1 | 2006 | 393 | 0.230 |
Why?
| | Female | 17 | 2024 | 68777 | 0.220 |
Why?
| | Fetomaternal Transfusion | 1 | 2023 | 11 | 0.210 |
Why?
| | Health Services | 1 | 2023 | 99 | 0.190 |
Why?
| | Child, Preschool | 5 | 2020 | 10517 | 0.190 |
Why?
| | Graft vs Host Disease | 1 | 2023 | 241 | 0.180 |
Why?
| | Hemostatics | 1 | 2021 | 49 | 0.180 |
Why?
| | Premedication | 1 | 2020 | 42 | 0.170 |
Why?
| | Practice Patterns, Physicians' | 2 | 2022 | 1266 | 0.170 |
Why?
| | Practice Guidelines as Topic | 2 | 2020 | 1501 | 0.170 |
Why?
| | Research | 1 | 2023 | 416 | 0.160 |
Why?
| | Blood Coagulation Disorders | 1 | 2021 | 167 | 0.160 |
Why?
| | Cost of Illness | 1 | 2021 | 278 | 0.150 |
Why?
| | Physical Therapy Modalities | 1 | 2022 | 292 | 0.150 |
Why?
| | Pregnancy Complications | 1 | 2023 | 493 | 0.150 |
Why?
| | Activities of Daily Living | 2 | 2018 | 384 | 0.150 |
Why?
| | Health Care Costs | 1 | 2021 | 367 | 0.140 |
Why?
| | Musculoskeletal Pain | 1 | 2017 | 34 | 0.140 |
Why?
| | Prospective Studies | 2 | 2022 | 7133 | 0.140 |
Why?
| | Comorbidity | 2 | 2018 | 1547 | 0.130 |
Why?
| | Child | 5 | 2020 | 20883 | 0.130 |
Why?
| | Prevalence | 2 | 2020 | 2564 | 0.130 |
Why?
| | Blood Coagulation Factor Inhibitors | 1 | 2015 | 4 | 0.120 |
Why?
| | Patient Acceptance of Health Care | 1 | 2021 | 759 | 0.120 |
Why?
| | Publications | 1 | 2014 | 41 | 0.110 |
Why?
| | Risk Factors | 3 | 2020 | 9765 | 0.110 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 913 | 0.110 |
Why?
| | Infant | 3 | 2020 | 9024 | 0.110 |
Why?
| | Infant, Newborn | 2 | 2020 | 5762 | 0.110 |
Why?
| | Medical Oncology | 2 | 2024 | 272 | 0.100 |
Why?
| | Remission, Spontaneous | 1 | 2012 | 38 | 0.100 |
Why?
| | Quality Improvement | 1 | 2021 | 1103 | 0.100 |
Why?
| | Self Report | 1 | 2017 | 799 | 0.100 |
Why?
| | Enterocolitis, Pseudomembranous | 1 | 2012 | 28 | 0.100 |
Why?
| | Sickle Cell Trait | 1 | 2012 | 13 | 0.100 |
Why?
| | Case Management | 1 | 2012 | 64 | 0.090 |
Why?
| | Odds Ratio | 2 | 2015 | 1023 | 0.090 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2016 | 305 | 0.090 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2012 | 82 | 0.090 |
Why?
| | Thrombophilia | 1 | 2012 | 81 | 0.090 |
Why?
| | Hospitalization | 1 | 2021 | 2070 | 0.090 |
Why?
| | Sex Factors | 1 | 2017 | 1968 | 0.090 |
Why?
| | North Carolina | 1 | 2010 | 99 | 0.080 |
Why?
| | Ultrasonography, Doppler | 1 | 2010 | 118 | 0.080 |
Why?
| | Risk | 1 | 2012 | 854 | 0.080 |
Why?
| | Ultrasonography | 1 | 2012 | 716 | 0.070 |
Why?
| | Incidental Findings | 1 | 2006 | 79 | 0.060 |
Why?
| | Cohort Studies | 1 | 2016 | 5420 | 0.060 |
Why?
| | Diagnostic Errors | 1 | 2006 | 162 | 0.060 |
Why?
| | Logistic Models | 1 | 2010 | 1988 | 0.060 |
Why?
| | Recombinant Proteins | 2 | 2020 | 1304 | 0.060 |
Why?
| | Retrospective Studies | 1 | 2022 | 14518 | 0.060 |
Why?
| | Factor IX | 1 | 2024 | 42 | 0.060 |
Why?
| | Dependovirus | 1 | 2024 | 62 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 1 | 2012 | 2282 | 0.050 |
Why?
| | Reproducibility of Results | 2 | 2021 | 3083 | 0.050 |
Why?
| | Risk Assessment | 1 | 2010 | 3240 | 0.040 |
Why?
| | Half-Life | 1 | 2021 | 162 | 0.040 |
Why?
| | Plasmapheresis | 1 | 2020 | 23 | 0.040 |
Why?
| | Disease Management | 1 | 2024 | 589 | 0.040 |
Why?
| | Factor VIIa | 1 | 2020 | 39 | 0.040 |
Why?
| | Choice Behavior | 1 | 2021 | 165 | 0.040 |
Why?
| | Rituximab | 1 | 2020 | 164 | 0.040 |
Why?
| | Patient Preference | 1 | 2021 | 185 | 0.040 |
Why?
| | Fetus | 1 | 2023 | 773 | 0.040 |
Why?
| | Time-to-Treatment | 1 | 2020 | 180 | 0.040 |
Why?
| | Primary Prevention | 1 | 2020 | 188 | 0.040 |
Why?
| | Obesity | 1 | 2012 | 2883 | 0.040 |
Why?
| | Medication Adherence | 1 | 2023 | 558 | 0.040 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2023 | 573 | 0.040 |
Why?
| | Swine | 1 | 2020 | 760 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2020 | 522 | 0.030 |
Why?
| | Psychometrics | 1 | 2020 | 691 | 0.030 |
Why?
| | Patient-Centered Care | 1 | 2021 | 505 | 0.030 |
Why?
| | Time Factors | 1 | 2006 | 6556 | 0.030 |
Why?
| | Health Status | 1 | 2021 | 755 | 0.030 |
Why?
| | Perception | 1 | 2018 | 340 | 0.030 |
Why?
| | Stress, Psychological | 1 | 2023 | 1066 | 0.030 |
Why?
| | Demography | 1 | 2015 | 279 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2015 | 482 | 0.030 |
Why?
| | Prognosis | 1 | 2020 | 3794 | 0.020 |
Why?
| | Pregnancy | 1 | 2023 | 6402 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2021 | 7086 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2020 | 10230 | 0.020 |
Why?
| | Animals | 1 | 2020 | 35361 | 0.010 |
Why?
|
|
Buckner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|